AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2010
Sep 9, 2010
30583_dirs_2010-09-09_4ff5d810-0433-4f20-88cf-9be89382ccec.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2010-09-08
Reporting Person: ASELAGE STEVE (EVP, Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-09-08 | Common Stock | M | 35000 | $11.74 | Acquired | 72587 | Direct |
| 2010-09-08 | Common Stock | S | 35000 | $22.000 | Disposed | 37587 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-09-08 | Stock Option (right to buy) | $11.74 | M | 35000 | Disposed | 2016-01-05 | Common Stock (35000) | Direct |
Footnotes
F1: Transaction made pursuant to a Rule 105-1 Trading plan executed on March 10, 2010.
F2: Original option vests 12/36ths on July 1, 2006 and 1/36th on the 1st of every month thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19